ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

202155 citationsJournal Articlegold Open Access

Authors

Jean Bousquet · Humboldt-Universität zu Berlin

Oliver Pfaar · Philipps University of Marburg

Ioana Agache · Transylvania University of Brașov

Anna Bedbrook

Cezmi A. Akdiş · University of Zurich

Giorgio Walter Canonica · Humanitas University

Tomás Chivato · Universidad San Pablo CEU

Abstract

Allergen immunotherapy (AIT), the gradually increasing repeated administration of high doses of allergens to allergic patients, offers the potential for immune tolerance against reactions to the natural exposures to specific allergens. AIT may lead to the long-lasting remission of allergic symptoms and is the only disease-modifying intervention in IgE-mediated allergic respiratory diseases.

Topics & Keywords

Allergic Rhinitis and Sensitization Asthma and respiratory diseases

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Clinical and Translational Allergy

Volume 11, Issue 4, pp. e12014-e12014

DOI: 10.1002/clt2.12014

Field-Weighted Citation Impact: 5.53